# FDA Inspection 1283432 - Tae Min Kim, M.D., Ph.D. - August 29, 2025

Source: https://www.keypedia.com/records/fda_inspections/tae-min-kim-md-phd/7abbbfdb-c97f-4074-bc0d-ffae1ef686d5
Source feed: FDA_Inspections

> FDA Inspection 1283432 for Tae Min Kim, M.D., Ph.D. on August 29, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283432
- Company Name: Tae Min Kim, M.D., Ph.D.
- Inspection Date: 2025-08-29
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1283432 - 2025-08-29](https://www.keypedia.com/records/fda_inspections/tae-min-kim-md-phd/661eced6-eab1-4960-8c74-8972bb872e15)
- [FDA Inspection 1226038 - 2023-12-15](https://www.keypedia.com/records/fda_inspections/tae-min-kim-md-phd/5b01f199-5510-48c0-b796-1502e9666c59)

Company: https://www.keypedia.com/companies/tae-min-kim-md-phd/65edf818-9c47-4104-9173-571185503eff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c